Javascript must be enabled to continue!
Bioequivalence
View through CrossRef
Abstract
Bioequivalence is defined as the comparable bioavailability of alternative drug formulations. Kinetic measures of bioavailability are reviewed, leading to a discussion of the statistical assessment of bioequivalence. Parametric and nonparametric methods of testing are described. Current research areas, including the estimation of individual bioequivalence and alternative measures for the evaluation of bioequivalence, are reviewed.
Title: Bioequivalence
Description:
Abstract
Bioequivalence is defined as the comparable bioavailability of alternative drug formulations.
Kinetic measures of bioavailability are reviewed, leading to a discussion of the statistical assessment of bioequivalence.
Parametric and nonparametric methods of testing are described.
Current research areas, including the estimation of individual bioequivalence and alternative measures for the evaluation of bioequivalence, are reviewed.
Related Results
A Multicenter Randomized Bioequivalence Study of a Novel Ready-to-Use Temozolomide Oral Suspension vs. Temozolomide Capsules
A Multicenter Randomized Bioequivalence Study of a Novel Ready-to-Use Temozolomide Oral Suspension vs. Temozolomide Capsules
Background: Temozolomide (TMZ) oral suspension (Ped-TMZ, KIZFIZO®) is being developed for the treatment of relapsed or refractory neuroblastoma, a rare cancer affecting infants and...
Bioequivalence studies for pharmaceutical products
Bioequivalence studies for pharmaceutical products
This review is the summary of Bioequivalence, Bioavailability and its related parameters. Brief description of Bioavailability and Bioequivalence is explained along with the post a...
Bioequivalence Estimation of Two Formulations of Cefixime Tablets among Healthy Chinese Volunteers under Fasting Condition
Bioequivalence Estimation of Two Formulations of Cefixime Tablets among Healthy Chinese Volunteers under Fasting Condition
Objective: To assess the bioequivalence of 200mg Cefixime tablets after oral administration to healthy adults under fasting condition. Method: This study was an open-label, balanc...
Review of bioequivalence studies of cholecalciferol drugs
Review of bioequivalence studies of cholecalciferol drugs
Introduction: The general requirements for assessing bioequivalence of endogenous drugs are described in the relevant guidelines, but they do not provide a complete picture of how...
Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and to
Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and to
Background:
Hydrofluoroolefin-1234ze (HFO-1234ze) is a next-generation propellant with 99.9% lower global warming potential (GWP) than hydrofluoroalkane-134a (H...
Bioequivalence
Bioequivalence
Abstract
Bioequivalence is defined as the comparable bioavailability of alternative drug formulations. Kinetic measures of bioavailability are reviewed, leading to a disc...
Reversed Phase High Performance Liquid Chromatographic Method for Determination of Sildenafil in Human Plasma and its Application to a Bioequivalence Study
Reversed Phase High Performance Liquid Chromatographic Method for Determination of Sildenafil in Human Plasma and its Application to a Bioequivalence Study
Sildenafil Citrate is a drug used to treat erectile dysfunction and pulmonary arterial hypertension (PAH). A sensitive and specific method based on High Performance Liquid Chromato...
BioequivalenceArticle originally published in
Encyclopedia of Biostatistics, 2nd Edition
(2005, John Wiley & Sons, Ltd).
BioequivalenceArticle originally published in
Encyclopedia of Biostatistics, 2nd Edition
(2005, John Wiley & Sons, Ltd).
Abstract
Bioequivalence is defined as the comparable bioavailability of alternative drug formulations. Kinetic measures of bioavailability are reviewed, leading to a disc...

